Health risks

Journal of Photochemistry and Photobiology B: Biology

Volumn 46, Issue 1-3, 1998, Pages 20-39

  Longstreth, J ^a   De Gruijl, F R ^b   Kripke, M L ^c   Abseck, S ^d   Arnold, F ^e   Slaper, H I ^f   Velders, G ^f   Takizawa, Y ^g   Van Der Leun, J C ^b  

^a Institute for Global Risk Research LLC   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF TEXAS   (United States)

^d ICF INTERNATIONAL   (United States)

^e Natl Inst of Pub Hlth and the E ^*  (United States)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

Author keywords

Cataract; Chlorofluorocarbons; Health risks; Ozone depleting substances; Photoaging; Skin cancer; Ultraviolet B radiation

Indexed keywords

CHLOROFLUOROCARBON;

AIR POLLUTION; ARTICLE; BLINDNESS; CATARACT; HEALTH HAZARD; HUMAN; IMMUNE SYSTEM; KERATITIS; LIVER INJURY; MELANOMA; OCCUPATIONAL EXPOSURE; OZONE LAYER; PRIORITY JOURNAL; PTERYGIUM; RADIATION CARCINOGENESIS; RADIATION CATARACT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION;

ANIMALS; ENVIRONMENT; HEALTH; HUMANS; OZONE; RISK ASSESSMENT; SKIN; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 0032444642     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00183-3     Document Type: Article

References (167)

1. [1] J.C. Merriam, The concentration of light in the human lens, Trans. Amer. Ophthalmol. Soc. 94 (1996) 804-918.
2. [2] C.A. McCarty, H.R. Taylor, Recent developments in vision research, Invest. Ophthalmol. Visual Sci. 37 (1996) 1720-1723.
3. [3] M. Kennedy, K.H. Kim, B. Harten, J. Brown, S. Planck, C. Meshul, H. Edelhauser, J.T. Rosenbaum, C.A. Armstrong, J.C. Ansel, Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells, Invest. Ophthalmol. Visual Sci. 38 (1997) 2483-2491.
4. [4] F.C. Hollows, Ultraviolet radiation and eye diseases, Trans. Menzies Foundation 15 (1989) 113-117.
5. [5] H.R. Taylor, S.K. West, F.S. Rosenthal, B. Munoz, H.S. Newland, E.A. Emmett, Corneal changes associated with chronic UV irradiation, Arch. Ophthalmol. 107 (1989) 1481-1484.
6. [6] F.D. Mackenzie, L.W. Hirst, D. Battistutta, A. Green, Risk analysis in the development of pterygia, Ophthalmology 99 (1992) 1056-1061.
7. [7] J.P.G. Bergmanson, T.M. Sheldon, Ultraviolet radiation revisited, CLAO 23 (1997) 196-204.
8. [8] R. Newton, J. Ferlay, G. Reeves, V. Beral, D.M. Parkin, Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye, Lancet 347 (1996) 1450-1451.
9. [9] R. Berkow, Ophthalmologic disorders, in: R. Berkow (Ed.), The Merck Manual, ch. 17, Merck Research Laboratories, Rahway, NJ, 1992.
10. [10] E.A. Holly, D.A. Aston, D.K. Ahn, A.H. Smith, Intraocular melanoma linked to occupations and chemical exposures, Epidemiology 7 (1996) 55-61.
11. [11] P.J. Dolin, Assessment of the epidemiological evidence that exposure to solar ultraviolet radiation causes cataract, Doc. Ophthalm. 88 (1995) 585-590.
12. [12] L.H. Schwartz, R. Ferrand, P.Y. Boelle, C. Maylin, F. D'Hermies, J. Virmont, Lack of correlation between the location of choroidal melanoma and ultraviolet-radiation dose distribution, Radiation Res. 147 (1997) 451-456.
13. [13] K. Hiramoto, Y. Mashita, T. Katada, H. Konishi, M. Sugiura, R. Hayakawa, Immunosuppression by ultraviolet B rays via eyes in mice, Arch. Dermatol. Res. 289 (1997) 709-711.
14. [14] Italian-American Cataract Study Group, Risk factors for age-related cortical, nuclear and posterior subcapsular cataracts, Amer. J. Epidemiol. 133 (1991) 542-553.
15. [15] Italian-American Cataract Study Group, Incidence and progression of cortical, nuclear and posterior subcapsular cataract, Amer. J. Ophthalmol. 118 (1994) 623-631.
16. [16] B.E.K. Klein, K.J. Cruickshanks, R. Klein, Leisure time, sunlight exposure and cataracts, Documenta Ophthalmologica 88 (1995) 295-305.
17. [17] S.K. West, C.T. Valmadrid, Epidemiology of risk factors for age-related cataract, Surveys Ophthalmology 39 (1995) 323-335.
18. [18] S.K. West, D.D. Duncan, B. Munoz, G.S. Rubin, L.P. Fried, K. Bandeen-Roche, O.D. Schein, Sunlight exposure and the risk of lens opacities in a population-based study: the Salisbury eye evaluation project, JAMA 280 (1998) 714-718.
19. [19] J.C. Javitt, H.R. Taylor, Cataract and latitude, Documenta Ophthalmologica 88 (1995) 307-325.
20. [20] M.S. Fisher, M.L. Kripke, Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis, Proc. Natl. Acad. Sci. USA 74 (1977) 1688-1692.
21. [21] M.L. Kripke, Immunological unresponsiveness induced by ultraviolet radiation, Immunol. Revs. 80 (1984) 87-102.
22. [22] T. Yoshikawa, V. Rae, W. Bruin-Slot, W. Van den Berg, J.R. Taylor, J.W. Streilein, Susceptibility to effects of UV-B radiation on the induction of contact hypersensitivity as a risk for skin cancer in humans, J. Invest. Dermatol. 95 (1990) 530-536.
23. [23] K.D. Cooper, L. Oberhelman, T.A. Hamilton, O. Baardsgaard, M. Terhune, G. LeVee, T. Anderson, H. Koren, UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR + epidermal macrophage induction and Langerhans cell deletion, Proc. Natl. Acad. Sci. USA 89 (1992) 8497-8501.
24. [24] S. Howie, M. Norval, J. Maingay, Exposure to low-dose ultraviolet radiation suppressed delayed-type hypersensitivity to herpes simplex virus in mice, J. Invest. Dermatol. 86 (1986) 125-128.
25. [25] J.C. van der Leun, H. Van Weelden, UVB phototherapeutic principles, radiation sources, regimens, in: H. Hoenigsmann, G. Stingl (Eds.), Therapeutic Photomedicine, Karger, Basel, 1986, pp. 39-51.
26. [26] J.C. van der Leun, R.F. De Gruijl, Influences of ozone depletion on human and animal health, in: M. Tevini (Ed.), UVB Radiation and Ozone Depletion, Lewis Publishing, Boca Raton, FL, 1993, pp. 95-123.
27. [27] E.C. DeFabo, F.P. Noonan, Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for existence of a unique photoprotector in skin and its role in photoimmunology, J. Exp. Med. 158 (1983) 84-89.
28. [28] M.L. Kripke, P.A. Cox, L.G. Alas, D.B. Yarosh, Pyrimidine dimers in DNA initiate systemic suppression in UV-irradiated mice, Proc. Natl. Acad. Sci. USA 89 (1992) 7516-7520.
29. [29] J.W. Streilein, Photoimmunology of non-melanoma skin cancer, Cancer Surveys 26 (1996) 207-217.
30. [30] F.M. Stickland, M.L. Kripke, Immune response associated with nonmelanoma skin cancer, Clinics in Plastic Surgery 24 (1997) 637-647.
31. [31] Y. Devary, C. Rosette, J.A. DiDonata, M. Karin, NF-κB activation by ultraviolet light is not dependent on a nuclear signal, Science 261 (1993) 1442-1445.
32. 3 as a natural regulator of human immune functions, J. Invest. Dermatol. Symp. Proc. 1 (1996) 68-71.
33. [33] H. Niizeki, J.W. Streilein, Hapten-specific tolerance induced by acute low-dose ultraviolet B radiation of the skin is mediated via IL-10, J. Invest. Dermatol. 109 (1997) 25-30.
34. [34] J.W. Streilein, P.R. Bergstresser, Genetic basis of ultraviolet-B effects on contact hypersensitivity, Immunogenetics 27 (1988) 398-405.
35. [35] T. Yoshikawa, J.W. Streilein, Genetic basis of the effects of ultraviolet light B on cutanteous immunity. Evidence that polymorphism at the Trfa and LPS loci governs susceptibility, Immunogenetics 32 (1990) 398-405.
36. [36] M. Yamawaki, S.K. Katiyar, C.Y. Anderson, K.A. Tubesing, H. Mukhtar, C.A. Elmets, Genetic variation in low-dose UV-induced suppression of contact hypersensitivity and in skin photocarcinogenesis, J. Invest. Dermatol. 109 (1997) 716-721.
37. [37] A. Screibner, D.E. Hollis, E. Murray, W.H. McCarthy, G.W. Milton, Effects of exposure to ultraviolet light on epidermal Langerhans cells and melanocytes in Australians of Aboriginal, Asian and Celtic descent, Photodermatology 3 (1987) 15-25.
38. [38] N.R. Finsen, Phototherapy, J.H. Sequira (transl.), Edward Arnold, London, 1901, p. 79.
39. [39] F.P. Noonan, F.A. Lewis, UVB-induced immune suppression and infection with Schistosoma mansoni, Photochem. Photobiol. 61 (1995) 99-105.
40. [40] M.S.H. Giannini, E.C. DeFabo, Abrogation of skin lesions in cutanteous leishmaniasis, in: D.T. Hart (Ed.), Leishmaniasis: the First Centenary (1885-1985). New Strategies for Control, NATO ASI Series A: Life Sciences, Plenum, London, 1987.
41. [41] Y. Denkins, I.J. Fidler, M.L. Kripke, Exposure of mice to UVB radiation suppresses delayed hypersensitivity to Candida albicans, Photochem. Photobiol. 49 (1989) 615-619.
42. [42] A. Jeevan, M.L. Kripke, Impact of ozone depletion on immune function, World Resources Rev. 5 (1993) 141-155.
43. [43] W. Goettsch, J. Garssen, A. Deijns, F.R. de Gruijl, H. van Loveren, UV-B exposure impairs resistance to infection by Trichinella spiralis, Environ. Health Perspect. 102 (1994) 298-301.
44. [44] S.L. Spruance, Pathogenesis of herpes simplex labialis: experiment induction of lesions with UV light, J. Clin. Microbiol. 22 (1985) 366-468.
45. [45] J.J. Perna, M.L. Manix, J.E. Rooney, A.D. Notkins, S.E. Straus, Reactivation of latent herpes simplex virus infection by ultraviolet radiation: a human model, J. Amer. Acad. Dermatol. 17 (1987) 197-212.
46. [46] B.Z. Zmudzka, J.B. Beer, Activation of human immunodeficiency virus by ultraviolet radiation, Photochem. Photobiol. 6 (1990) 1153-1162.
47. [47] M. Norval, A.A. el Ghorr, UV radiation and mouse models of herpes simplex virus infection, Photochem. Photobiol. 64 (1996) 242-245.
48. [48] W. Goettsch, J. Garssen, F.R. De Gruijl, H. Van Loveren, UVB-induced decreased resistance to Trichinella spiralis in the rat is related to impaired cellular immunity, Photochem. Photobiol. 54 (1996) 581-585.
49. [49] A.J. Saah, T.D. Horn, D.R. Hoover, C. Chen, S.E. Whitmore, C. Flynn, J. Wesch, R. Detels, R. Anderson, Solar ultraviolet radiation exposure does not appear to exacerbate HIV infection in homosexual men, AIDS 11 (1997) 1773-1778.
50. [50] H. McGrath, J.M. Bell, J.W. Haycock, Fluorescent light activates the immunomodulator cis-urocanic acid in vitro: implications for patients with systemic lupus erythematosus, Ann. Rheumatic Diseases 53 (1994) 396-399.
51. [51] D.R. Lucey, M. Clerici, G.M. Shearer, Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases, Clin. Microbiol. Revs. 9 (1996) 532-562.
52. [52] S.E. Ullrich, The role of epidermal cytokines in the generation of cutaneous immune reactions and ultraviolet radiation-induced immune suppression, Photochem. Photobiol. 62 (1995) 389-401.
53. [53] A. Boonstra, H.F.J. Savelkoul, The role of cytokines in ultraviolet B induced immunosuppression, Eur. Cytokine Network 8 (1997) 117-123.
54. [54] J.S. Koh, J.S. Levine, Apoptosis and autoimmunity, Current Opinion Nephrology Hypertension 16 (1997) 259-266.
55. [55] Y. Aragane, D. Kulms, D. Metze, G. Wilkes, B. Poppelmann, T.A. Luger, T. Schwartz, Ultraviolet light induced apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L, J. Cell Biol. 140 (1998) 171-182.
56. [56] R.J. Sharpe, The low incidence of multiple sclerosis near the equator may be due to ultraviolet light induced suppressor cells to melanocyte antigens, Medical Hypotheses 19 (1986) 319-323.
57. [57] A.J. McMichael, A.J. Hall, Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis?, Epidemiology 8 (1997) 642-645.
58. [58] M. Garmyn, H. Degreef, B.A. Gilcrest, The effect of acute and chronic photodamage on gene expression in human keratinocytes, Dermatology 190 (1995) 305-308.
59. [59] M.A. Pathak, Activation of the melanocyte system by ultraviolet radiation and cell transformation, Ann. NY Acad. Sci. 453 (1985) 328-339.
60. [60] A.M. Kligman, L.H. Kligman, Photoaging, in: T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedberg, K.F. Austen (Eds.), Dermatology in General Medicine, 4th ed., McGraw-Hill, New York, 1993, pp. 2972-2979.
61. [61] K. Scharffetter-Kochanek, M. Wiaschek, P. Brenneisen, M. Schauen, R. Blaudschun, J. Wenk, UV-induced reactive oxygen species in photocarcinogenesis and photoaging, Biol. Chem. 378 (1997) 1247-1257.
62. [62] C. Kut, W. Hornebeck, N. Groult, G. Redziniack, G. Godeau, B. Pellat, Influence of successive and combined ultraviolet A and B on matrix metalloelastases produced by human dermal fibroblasts in culture, Biol. Int. 21 (1997) 347-352.
63. [63] R.P. Gallagher, G.B. Hill, C.D. Bajdik, S. Fincham, A.J. Coldman, D.I. McLean, W.J. Trefall, Sunlight exposure, pigmentary factors and the risk of nonmelanocytic skin cancer I: basal cell carcinoma, Arch. Dermatol. 131 (1995) 157-163.
64. [64] J.H. Epstein, Nonmelanoma skin cancer, Comprehensive Therapeutics 22 (1996) 179-182.
65. [65] W.E. Hoy, Nonmelanoma skin carcinoma in Albuquerque, New Mexico - experience of a major health care provider, Cancer 77 (1996) 2489-2495.
66. [66] R. Marks, M. Staples, G.G. Giles, Trends in non-melanocytic skin cancer treated in Australia: the second national survey, Int. J. Cancer 53 (1993) 585-590.
67. [67] J. Scotto, T.R. Fears, J.F. Fraumeni, Jr., Incidence of nonmelanoma skin cancer in the United States, National Cancer Institute, US Department of Health and Human Services, NIH 82-2433, 1981.
68. [68] A. Kricker, B.K. Armstrong, D.R. English, P.J. Heenan, A dose-response curve for sun exposure and basal cell carcinoma, Int. J. Cancer 60 (1995) 482-488.
69. [69] A. Kricker, B.K. Armstrong, D.R. English, P.J. Heenan, Does intermittent sun exposure cause basal cell carcinoma?, Int. J. Cancer 60 (1995) 489-494.
70. [70] B.C. Vitasa, H.R. Taylor, P.T. Strickland, F.S. Rosenthal, S. West, H. Abbey, S.K. Ng, B. Munoz, E.A. Emmett, Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen, Cancer 65 (1990) 2811-2817.
71. [71] R.S. Stern, M.C. Weinstein, S.G. Baker, Risk reduction for nonmelanoma skin cancer with childhood sunscreen use, Arch. Dermatol. 122 (1986) 537-545.
72. [72] S. Rosso, R. Zanetti, C. Martinez, M.J. Tormo, S. Schraub, H. Sancho-Garnier, S. Franceschi, L. Gafa, E. Perea, C. Navarro, R. Laurent, C. Schrameck, R. Talamini, R. Tumino, J. Wechsler, The multicentre south European study 'Helios' II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin, Br. J. Cancer 73 (1996) 1447-1454.
73. [73] R.P. Gallagher, G.B. Hill, C.D. Bajdik, S. Fincham, A.J. Coldman, D.I. McLean, W.J. Trefall, Sunlight exposure, pigmentary factors and the risk of nonmelanocytic skin cancer II: squamous cell carcinoma, Arch. Dermatol. 131 (1995) 164-169.
74. [74] S.C. Thompson, D. Jolley, R. Marks, Reduction in solar keratoses by regular sunscreen use, New England J. Med. 329 (1993) 1147-1151.
75. [75] A. Kricker, Sun exposure and non-melanocytic skin cancer, Dissertation, University of Western Australia, Perth, 1992.
76. [76] F. Grodstein, F.S. Speizer, D.J. Hunter, A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study, J. Natl. Cancer Inst. 87 (1995) 1061-1066.
77. [77] B.K. Armstrong, A. Kricker, D.R. English, Aetiology and pathogenesis of skin cancer, Aust. J. Dermatol. 58 (Suppl.) (1997) S1-S6.
78. [78] D.E. Brash, J.A. Rudolph, J.A. Simon, A. Lin, G.J. McKenna, H.P. Baden, A.J. Halparin, J. Ponten, A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinomas, Proc. Natl. Acad. Sci. USA 88 (1991) 10124-10128.
79. [79] A. Ziegler, D.J. Leffel, S. Kunala, H.W. Sharma, M. Gailani, J.A. Simon, A.J. Halperin, P.E. Shapiro, A.E. Bale, D.E. Brash, Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers, Proc. Natl. Acad. Sci. USA 90 (1993) 4216-4220.
80. [80] A. Ziegler, A.S. Jonason, D.J. Leffel, A. Simon, H.W. Sharma, J. Kimmelman, L. Remington, T. Jacks, D.E. Brash, Sunburn and p53 in the onset of skin cancer, Nature 372 (1994) 773-776.
81. [81] S. Kress, C. Sutter, P.T. Strickland, H. Mukhtar, J. Schweizer, M. Schwaitz, Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin, Cancer Res. 52 (1992) 6400-6403.
82. [82] S. Kanjilal, W.E. Pierceall, K.K. Cummings, M.L. Kripke, H.N. Ananthaswamy, High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogenicity, Cancer Res. 53 (1993) 2961-2964.
83. [83] N. Dumaz, H.J. Van Kranen, A. De Vries, R.J.W. Berg, P.W. Wester, C.F. Van Kreijl, A. Sarasin, L. Daya-Grosjean, F.R. De Gruijl, The role of UVB light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice, Carcinogenesis 18 (1997) 897-904.
84. [84] H.D. Nakazawa, D. English, P.L. Randell, K. Nakazawa, N. Martel, B.K. Armstrong, H. Yamasaki, UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement, Proc. Natl. Acad. Sc. USA 91 (1994) 360-363.
85. [85] R.J.W. Berg, H.J. Van Kranen, H.G. Rebel, A. De Vries, W.A. Van Vloten, C.F. Van Kreijl, J.C. Van der Leun, F.R. De Gruijl, Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells, Proc. Natl. Acad. Sci. USA 93 (1996) 14025-14029.
86. [86] Z.P. Ren, F. Pontén, M. Nistér, J. Pontén, Two distinct p53 immunohistochemical patterns in human squamous cell skin cancer, precursors and normal epidermis, Int. J. Cancer 69 (1996) 174-179.
87. [87] D.E. Brash, A. Ziegler, A.S. Jonason, J.A. Simon, S. Kunala, D.J. Leffell, Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion, J. Invest. Dermatol. Symp. Proc. 1 (1996) 136-142.
88. [88] T. Nomura, H. Nakajima, T. Hongyo, E. Taniguchi, K. Fukuda, L.Y. Li, M. Kurooka, K. Sutoh, P.M. Hande, T. Kawaguchi, M. Ueda, H. Takatera, Induction of cancer, actinic keratosis and specific p53 mutations by UVB light in human skin maintained in severe combined immunodencient mice, Cancer Res. 57 (1997) 2081-2084.
89. [89] M. Elwood, J. Jopson, Melanoma and sun exposure: an overview of published studies, J. Cancer 73 (1997) 198-203.
90. [90] C.D.J. Holman, B.K. Armstrong, Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types, J. Natl. Cancer Inst. 73 (1984) 75-82.
91. [91] C.D.J. Holman, B.K. Armstrong, Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma, J. Natl. Cancer Inst. 73 (1984) 75-82.
92. [92] P. Autier, J.-F. Doré, Influence of sun exposures during childhood and during adulthood on melanoma risk, Int. J. Cancer 77 (1998) 533-537.
93. [93] R.P. Gallagher, D.I. McLean, The epidemiology of acquired melanocytic nevi - a brief review, Dermatology Clinics 13 (1995) 595-603.
94. [94] USEPA (US Environmental Protection Agency), Nonmelanoma skin cancer, Cutaneous malignant melanoma, and Cataract, in: Assessing the Risks of Trace Gases That Can Modify the Stratosphere, EPA 400/1-87/001C, 1987, ch. 7, pp. 7-1-7-66, ch. 8, pp. 8-1-8-51, ch. 10, pp. 10-1-10-48.
95. [95] V. Bataille, A. Grulich, P. Sasieni, A. Swerdlow, J. Newton Bishop, W. McCarthy, P. Hersey, J. Cuzick, The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia, Br. J. Cancer 77 (1998) 505-510.
96. [96] M.C. Berwick, Epidemiology: current trends, risk factors and environmental concerns, in: C.M. Balch, A.N. Houghton, A.J. Sober, S.-J. Soong (Eds.), Cutaneous Melanoma, Quality Medical Publishing, St Louis, MO, 1998, pp. 551-571.
97. [97] R.B. Setlow, E. Grist, K. Thompson, A.D. Woodhead, Wavelengths effective in the induction of malignant melanoma, Proc. Natl. Acad. Sci. USA 71 (1993) 3363-3366.
98. [98] F.R. de Gruijl, H.J.C.M. Sterenborg, P.D. Forbes, R.E. Davies, C. Cole, G. Kelfkens, H. van Weelden, H. Slaper, J.C. van der Leun, Wavelength dependence of skin cancer induction by ultraviolet radiation of albino hairless mice. Cancer Res. 53 (1993) 53-60.
99. [99] R.D. Ley, Ultraviolet radiation A-induced precursors of cutaneous melanoma in Mondelphis domestica, Cancer Res. 57 (1997) 3682-3684.
100. [100] J.D. Longstreth, Melanoma genesis: putative causes and possible mechanisms, in: C.M. Balch, A.N. Houghton, A.J. Sober, S.-J. Soong (Eds.), Cutaneous Melanoma, Quality Medical Publishing, St Louis, MO, 1998, pp. 535-550.
101. [101] A.M. Hargis, A review of solar induced lesions in domestic animals, Compendium Continuing Educ. 3 (1981) 287-300.
102. [102] A. Méndez, J. Pérez, E. Ruiz-Villamor, M.P. Martin, E. Mozos, Clinicopathological study of an outbreak of squamous cell carcinoma in sheep, Veterinary Record 141 (1997) 597-600.
103. [103] J.P. Teifke, C.V. Lohr, Immunohistochemical detection of p53 over-expression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs, J. Compar. Pathol. 114 (1996) 205-210.
104. [104] K.E. Kopecky, G.W. Pugh, D.E. Hughes, Wavelength of ultraviolet radiation that enhances onset of critical infectious bovine keratoconjunctivitis, Amer. J. Veterinary Res. 41 (1980) 1412-1415.
105. [105] S.J. Mayer, Stratospheric ozone depletion and animal health, Veterinary Record 131 (1992) 120-122.
106. [106] O.D. Schein, C. Vicencio, B. Munoz, K.N. Gelatt, D.D. Duncan, J. Nethercott, J. Honeyman, H.S. Koren, S. West, Ocular and dermatologic health effects of ultraviolet radiation exposure from the ozone hole in southern Chile, Amer. J. Public Health 85 (1995) 546-550.
107. [107] G.T. Reizner, T.Y. Chuang, D.J. Elpern, J.L. Stone, E.R. Farmer, Basal cell carcinoma and keratoacanthoma in Hawaiians: an incidence report, J. Acad. Dermatol. 29 (1993) 780-782.
108. [108] T.-Y. Chuan, G.T. Reizner, D.J. Elpern, J.L. Stone, E.R. Farmer, Non-melanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report, J. Amer. Acad. Dermatol. 33 (1995) 422-426.
109. [109] R. Hiller, R.D. Sperduto, F. Ederer, Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey, Amer. J. Epidemiol. 118 (1983) 239-249.
110. [110] P. Valverde, E. Healy, I. Jackson, J.L. Rees, A.J. Thody, Variants of the melanocyte stimulating hormone receptor gene are associated with red hair and fair skin in humans, Nature Genetics 11 (1995) 328-330.
111. [111] P. Valverde, E. Healy, S. Sikkink, F. Haldane, A.J. Thody, A. Carothers, I.J. Jackson, J.L. Rees, The Asp84glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma, Human Molec. Genet. 5 (1996) 1663-1666.
112. [112] R. Kerb, J. Brockmöller, T. Reum, I. Roots, Deficiency of glutathione s-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity, J. Invest. Dermatol. 108 (1997) 229-232.
113. [113] K.H. Kraemer, M.M. Lee, J. Scotto, DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum, Carcinogenesis 5 (1984) 511-514.
114. [114] J. Alcalay, E.E. Freeman, L.H. Goldberg, J.E. Wolf, Excision repair of pyrimidine dimers induced by simulated solar radiation in the skin of patients with basal cell carcinoma, J. Invest, Dermatol. 95 (1990) 506-509.
115. [115] Q. Wei, G.M. Matanoski, E.R. Farmer, M.A. Hedayati, L. Grossman, DNA repair and aging in basal cell carcinoma: a molecular epidemiology study, Proc. Natl. Acad. Sci. USA 90 (1993) 1614-1618.
116. [116] J. Hall, D.R. English, M. Artuso, B.K. Armstrong, M. Winter, DNA repair capacity as a risk factor for non-melanocytic skin cancer -a molecular epidemiological study, Int. J. Cancer 58 (1994) 179-184.
117. [117] C. Ahrens, M. Grewe, M. Berneburg, S. Grether-Beck, X. Quilliet, M. Mezzina, A. Sarasin, A.R. Lehmann, C.F. Arlett, J. Krutmann, Photocarcinogenesis and inhibition of intercellular adhesion molecule 1 expression in cells of DNA-repair-defective individuals, Proc. Natl. Acad. Sci. USA 94 (1997) 6837-6841.
118. [118] M.F. Naylor, M.A. Everett, Involvement of the p16INK4 (CDKN2) gene in familial melanoma, Melanoma Res. 6 (1996) 139-145.
119. [119] J.W. Fountain, Genetic factors, in: C.M. Balch, A.N. Houghton, A.J. Sober, S.-J. Soong (Eds.), Cutaneous Melanoma, Quality Medical Publishing, St Louis, MO, 1998, pp. 475-492.
120. [120] W.G. Hodge, J.P. Whitcher, W. Satariano, Risk factors for age-related cataracts, Epidemiol. Revs. 17 (1995) 336-346.
121. [121] S.D. Varma, P.S. Devamanoharan, S.M. Morris, Prevention of cataracts by nutritional and metabolic antioxidants, Crit. Revs. Food Sci. Nutrition 35 (1995) 111-129.
122. [122] S.S. Strom, Y. Yamamura, Epidemiology of nonmelanoma skin cancer, Clinics in Plastic Surgery 24 (1997) 627-636.
123. [123] B.K. Armstrong, A. Kricker, Skin cancer, Dermatol. Clinics 13 (1995) 583-594.
124. [124] M.M. Harteveld, J.N. Bouwes Bavinck, A.M.M. Kootte, B.J. Vermeer, J.P. Vandenbroucke, Incidence of skin cancer after renal transplantation in The Netherlands, Transplantation 49 (1990) 506-509.
125. [125] L.M. Tieben, R.J.M. Berkhout, H.L. Smits, J.N. Bouwes Bavinck, B.J. Vermeer, J.A. Bruijn, F.J. Van der Woude, J. Ter Schegget, Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients, Br. J. Dermatol. 131 (1994) 226-230.
126. [126] M. Kawashima, M. Favre, S. Obalak, S. Jablonska, G. Orth, Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses, J. Invest. Dermatol. 95 (1990) 537-542.
127. [127] I.L. Boxman, R.J. Berkhout, L.H. Mulder, M.C. Wolkers, J.N. Bouwes Bavinck, B.J. Vermeer, J. ter Schegget, Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers, J. Invest. Dermatol. 108 (1997) 712-715.
128. [128] J.M. McGregor, R.J.M. Berkhout, M. Rozycka, J. ter Schegget, J.N. Bouwes-Bavinck, L. Brooks, T. Crook, p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status, Oncogene 15 (1997) 1737-1740.
129. [129] H.J. Deeg, R.P. Witherspoon, Risk factors for the development of secondary malignancies after marrow transplantation, Hematology/ Oncology Clinics North America 7 (1993) 417-429.
130. [130] M. Frisch, M. Melbye, New primary cancers after squamous cell skin cancer, Amer. J. Epidemiol. 141 (1995) 916-922.
131. [131] M. Frisch, H. Hjalgrim, J.H. Olsen, M. Melbye, Risk of subsequent cancer after diagnosis of basal cell carcinoma: a population-based epidemiological study, Ann. Intern. Med. 125 (1994) 815-821.
132. [132] J. Adami, M. Frisch, J. Yuen, B. Glimelius, M. Melbye, Evidence of an association between non-Hodgkin's lymphoma and skin cancer, Br. Med. J. 310 (1995) 1491-1495.
133. [133] R. Cartwright, R. McNally, A. Staines, The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight, Leukemia Lymphoma 14 (1994) 387-394.
134. [134] L.H. Goldberg, Basal cell carcinoma as a predictor of other cancers, The Lancet 349 (1997) 664-665.
135. [135] F. Hirayama, M. Ogawa, Cytokine regulation of early B-lymphopoiesis assessed in culture, Blood Cells 20 (1994) 341-346.
136. [136] G. Bentham, Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales, Br. Med. J. 312 (1996) 1128-1131.
137. [137] P. Hartge, S.S. Devesa, D. Grauman, T.R. Fears, J.F. Fraumeni Jr, Non-Hodgkin's lymphoma and sunlight, J. Natl. Cancer Inst. 88 (1996) 298-300.
138. [138] Z. Husain, M.A. Pathak, T. Flotte, M.M. Wick, Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation, Cancer Res. 51 (1991) 4964-4970.
139. [139] M.L. Adams, K.R. Houpt, P.D. Cruz Jr., Is phototherapy safe for HIV-infected individuals?, Photochem. Photobiol. 64 (1996) 234-237.
140. [140] T. Meola, N.A. Soter, R. Ostreicher, M. Sanchez, J.A. Moy, The safety of UVB phototherapy in patients with HIV infection, J. Amer. Acad. Dermatol. 29 (1993) 216-220.
141. [141] R.S. Stern, N. Laird, The carcinogenic risk of treatments for severe psoraisis, Cancer 73 (1994) 2759-2764.
142. [142] R.S. Stern, K.T. Nichols, L.H. Vakeva, Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study, New England J. Med. 336 (1997) 1041-1045.
143. [143] A.J. Nataraj, P. Wolf, L. Cerroni, H.N. Ananthaswamy, p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA), J. Invest. Dermatol. 109 (1997) 238-243.
144. [144] USEPA (US Environmental Protection Agency) Regulatory Impact Analysis: Protection of Stratospheric Ozone, Stratospheric Protection Program, Office of Air and Radiation, US Environmental Protection Agency, 1988.
145. [145] J.C. van der Leun, M. Tevini, X. Tang, R.C. Worrest (Eds.), Environmental Effects of Ozone Depletion: 1994 Update, United Nations Environment Programme, Nairobi, 1994.
146. [146] J.D. Longstreth, F.R. De Gruijl, M.L. Kripke, Y. Takizawa, J.C. Van der Leun, Effects of increased solar ultraviolet radiation on human health, Ambio 24 (1995) 153-165.
147. [147] S. Madronich, F.R. DeGruiji, Skin cancer and UV radiation, Nature 366 (1993) 23.
148. [148] F.R. de Gruijl, J.C. van der Leun, Estimate of the wavelength dependency of ultraviolet carcinogenesis in humans and its relevance to the risk assessment of a stratospheric ozone depletion, Health Physics 67 (1994) 319-325.
149. [149] J.C. van der Leun, Y. Takizawa, J.D. Longstreth, Human Health, in: J.C. van der Leun, M. Tevini, R.C. Worrest (Eds.), Environmental Effects Panel Report, ch. 2, United Nations Environment Programme, Nairobi, 1991.
150. [150] J.C. van der Leun, M. Tevini, X. Tang, R.C. Worrest (eds.), Environmental Effects of Ozone Depletion: 1998 Update, United Nations Environment Programme, Nairobi, 1998.
151. [151] R. Rubenstein, personal communication.
152. [152] H. Slaper, G.J.M. Velders, J.S. Daniel, F.R. De Gruijl, J.C. Van der Leun, Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements, Nature 384 (1996) 256-258.
153. [153] F. Arnold, S. Abseck, J. Longstreth, H. Pitcher, R. Rubenstein, Stratospheric ozone depletion and future US melanoma mortality, 1998 in preparation.
154. [154] D.L. Albrirton, P.J. Aucamp, G. Megie, R.T. Watson (Eds.), Scientific assessment of ozone depletion: 1998, in: Global Ozone Research and Monitoring Project, World Meteorological Organization, Geneva, 1998 in press.
155. [155] F.R. de Gruijl, Health effects from solar UV radiation, Radiation Protection Dosimetry 72 (1997) 177-196.
156. [156] W. Goettsch, J. Garssen, W. Slob, F.R. De Gruijl, H. Van Loveren, Risk assessment for the harmful effects of UVB radiation on the immunological resistance to infectious diseases. Environ. Health Perspect. 106 (1998) 71-77.
157. [157] D.A. Stringer (Ed.), Joint Assessment of Commodity Chemicals No.16. Dichlorofluoromethane (HCFC-21) CAS:75-43-4, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), Brussels, Belgium, 1990.
158. [158] F.M. Carpanini (Ed.), Joint Assessment of Commodity Chemicals No. 9. Chlorodifluoromethane CAS: 75-45-6, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), Brussels, Belgium, 1989.
159. [159] D.A. Stringer (Ed.), Joint Assessment of Commodity Chemicals No. 25. 1-Chloro-1,2,2,2-tetrafluoroethane (HCFC 124) CAS No. 2873-89-0, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), Brussels, Belgium, 1994.
160. [160] D.A. Stringer (Ed.), Joint Assessment of Commodity Chemicals No.29. 1,1-Dichloro-1-nuoroethane (HCFC-141b).CAS No 1717-00-6, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), Brussels, Belgium, 1994.
161. [161] F.M. Carpanini (ed.), Joint Assessment of Commodity Chemicals No.11. 1,2,-Dichloro-1,1-difluoroethane (HFA-132b) CAS:1649-08-7, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1990, Brussels, Belgium.
162. [162] D.A. Stringer (Ed.), Joint Assessment of Commodity Chemicals No.14. 1-Chloro-2,2,2-trifluoroethane (HFA-133a), European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1990, Brussels, Belgium.
163. [163] D.A. Stringer (ed.), Joint Assessment of Commodity Chemicals No. 17. Chlorodifluorethane (1-chloro-1,1-difluoroethane; HFA 142b) CAS: 75-68-3, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1991, Brussels, Belgium.
164. [164] D.A. Stringer (ed.), Joint Assessment of Commodity Chemicals No.32. Difluoromethane (HFC-32) CAS No. 75-10-5, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1995, Brussels, Belgium.
165. [165] D.A. Stringer (ed.), Joint Assessment of Commodity Chemicals No.24. Pentafluoroethane (HFC 125) CAS No. 354-33-6, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1994, Brussels, Belgium.
166. [166] D.A. Stringer (ed.), Joint Assessment of Commodity Chemicals No.31. 1,1,1,2-Tetrafluoroethane (HFC-124a) CAS No. 811-97-2, European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1995, Brussels, Belgium.
167. [167] L. Turner (ed.), Joint Assessment of Commodity Chemicals No.4. Methylene chloride, CAS: 75-09-2,European Center for Ecotoxicology and Toxicology of Chemicals, Brussels (ECETOC), 1984, Brussels, Belgium.